In Vivo

Bayer’s US Playbook: The Smart Way To Top-Line Growth

By William Looney 14 Nov 2022

The hotly contested US market is central to Bayer’s aspirations to become a global innovation player in pharmaceuticals, especially in key growth segments like oncology. A little more than one year in, Bayer Pharmaceuticals Americas President Dr. Carsten Brunn reflects on his unit’s progress.

Pharmaprojects, Trialtrove, Citeline, TrialSc...

Tap into UK and Ireland drug development and trial activity trends

25 Aug 2022

Download your free infographic for a snapshot view of UK vs. EU4 clinical landscape

What Does The Pharma Industry Want From CROs?

15 Jun 2022

Get exclusive insights into what senior decision makers from small to large biotech and pharma companies want from contract research organizations.

Pharma Intelligence Apps

What Does The Pharma Industry Want From CDMOs?

13 May 2022

Based on a survey to over 100 of pharma’s senior decision makers, find out what organizations really want from CDMOs.

In Vivo

In Vivo Outlook 2021 Report

08 Oct 2021

The highly anticipated Outlook 2022 report from Pharma Intelligence is coming soon. Reach the thousands of senior decision makers who eagerly await this pharma industry ranking and review for the year ahead, with sponsorship opportunities that align your brand with our trusted information. 

Scrip

Scrip Asia 100

20 Sep 2021

The highly anticipated Scrip Asia 100 is back, and there are a limited number of opportunities for you to be a part of it. Don’t miss your chance to connect to APAC market leaders with a high-profile sponsorship of this essential annual financial performance ranking of pharma companies headquartered in the APAC region.

Scrip

Scrip Asia 100 Report Extract

26 Mar 2021

Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.

In Vivo

How To Obtain Effective Relief When A Global Pandemic Disrupts Your Supply Chain

By Dorothee Schramm and Katie von der Weid 27 Nov 2020

The COVID-19 pandemic is disrupting global supply chains and companies need effective tools to manage the related contract disputes. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, provide tips to help companies manage the situation.

In Vivo

Bayer US Pharmaceuticals' Sebastian Guth: Designs On A New Decade

By William Looney 27 Nov 2020

Bayer’s ambitious campaign to reposition itself as a global leader in two complementary fields – health and nutrition – will face its toughest test in the US, with its highly litigious approach to product liability and a tendency to target pharmaceuticals as the source of the health system’s affordability and access problems.